drugset

drugset / Trial / NCT00926016

Pioglitazone on Viral Kinetics, Cytokines and Innate Immunity in Insulin Resistant CHC GT 1 Subjects

NCT00926016 ↗

Completed 23 enrolled Brooke Army Medical Center The Geneva Foundation · collab

RandomizedParallel-groupOpen-label

Summary

The purpose of this study is to determine if rosiglitazone, a medicine used to treat diabetes, improves response to anti-viral treatment.

Timeline

Start: 2006-06
Primary completion: 2010-03
Completion: 2010-09

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Pioglitazone	Small molecule	45 mg	—

Indications